[Postoperative acute renal failure in adult patients with cardiac surgery: evaluation of the RIFLE classification].
OBJECTIVE
To evaluate the ability of the RIFLE classification to predict hospital mortality in adult patients who underwent cardiac surgery.


METHODS
From October 1st 2006 to December 31st 2006, five hundred and nine adult patients who underwent coronary artery bypass grafting and/or valve operation were enrolled in this study. Renal function was assessed daily according to the RIFLE classification, meanwhile, APACHE II score and SOFA score were also evaluated, as well as the maximum scores were recorded.


RESULTS
Mean duration of ventilation support was 18 (14-19) hours, the time of ICU stay was 1.4 +/- 1.0 days, and the time of postoperative hospital stay was 12.0 (10.0-15.0) days. 167 patients (32.8%) incurred postoperative ARF according to the RIFLE classification. The overall mortality was 4.3% (22/502). A significant increase (P < 0.01) was observed for mortality based on RIFLE classification. By applying the area under the receiver operating characteristic curve, the RIFLE classification had more powerful discrimination power [0.933, (95% CI 0.872-0.995), P < 0.001].


CONCLUSIONS
ARF is one of the major complications in postcardiotomy patients. Analytical data suggested the good discriminative power of the RIFLE classification for predicting inpatient mortality of adult postoperative patient with ARF, and the RIFLE classification is simple and practically performed. According to the RIFLE classification, patients with RIFLE class I or class F incur a significantly increased risk of in-hospital mortality compared with those who never develop ARF.
Yan
Xiao-Lei
XL
Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Li
Qun
Q
Hou
Xiao-Tong
XT
Li
Xiao-Mi
XM
Shao
Juan-Juan
JJ
Jia
Ming
M
Wan
Jiu-He
JH
Jia
Shi-Jie
SJ
D058186:Acute Kidney Injury / Q000145:classification* / Q000209:etiology* / Q000401:mortality; D000328:Adult; D000368:Aged; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012372:ROC Curve; D012720:Severity of Illness Index; D016019:Survival Analysis